Cdr grafted anti-cea antibodies and their production

Details Cdr grafted anti-cea antibodies and their production Cdr grafted anti-cea antibodies and their production

C - Chemistry, Metallurgy

12

P

C12P 21/08 (2006.01) A61K 39/395 (2006.01) C07K 16/46 (2006.01) C12N 15/13 (2006.01)

Patent

CA 2065325

The present invention provides humanised antibody molecules (HAMs) having specificity for carcinoembryonic antigen CEA) and having an antigen binding site wherein at least one of the complementarily determining regions (CDRs) of the var- iable domains is derived from the mouse monoclonal antibody A5B7 ( B7 MAb) and the remaining immunoglobulin-derived parts of the HAM are derived from a human immunoglobulin. The HA may be chimeric humanised antibodies or CDR-graft- ed humanised antibodies and are preferably produced by recombinant DNA techniques. The HAMs are useful for in vivo diag- nosis and therapy.

Affiliated with

Also associated with

Rating

Cdr grafted anti-cea antibodies and their production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cdr grafted anti-cea antibodies and their production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cdr grafted anti-cea antibodies and their production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1770793